Back
ESC Premium Access

Reverse remodeling by itself does not guarantee a low risk of life-threatening arrhythmic events and sudden cardiac death in cardiac resynchronization therapy patients. The GAUDI-CRT-Remod study.

Session: Poster session 6 - Cardiac resynchronisation therapy
Topic: Resynchronisation therapy
Speaker: Doctor A. Doltra (Barcelona, ES)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Doctor Adelina Doltra

Hospital Clinic of Barcelona, Barcelona (Spain)
0 follower

37 more presentations in this session

Cardiac resynchronization therapy in patients with Atrial Fibrillation. Predictors of sinUs rhythm REstoration (CRT-AF PURE).

Speaker: Associate Professor A. Darma (Leipzig, DE)

Access
Abstract
Slides
Like
Thumbnail

Mechanical dyssynchrony assessment improves the prognostic value of current guidelines based patient selection for CRT

Speaker: Doctor A. Beela (Maastricht, NL)

Access
Abstract
Slides
Like
Thumbnail

In CRT-D patients reverse remodeling and occurrence of VT/VF episodes, but not defibrillator therapies, are determinants of death or HF hospitalization risk.

Speaker: Doctor M. Landolina (Crema, IT)

Access
Abstract
Slides
Like
Thumbnail

Sex difference in the response to cardiac resynchronization therapy in patients with cardiac sarcoidosis: from Japanese multi-center retrospective cohort analysis.

Speaker: Doctor K. Nakasuka (San Francisco, US)

Access
Abstract
Slides
Like
Thumbnail

Improvement of reverse remodeling by using ECG Fusion Optimized Intervals (FOI) in cardiac resynchronisation therapy: a randomised study

Speaker: Doctor M. Trucco (Girona, ES)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 6 - Cardiac resynchronisation therapy

Speakers: Doctor A. Doltra, Associate Professor A. Darma, Doctor A. Beela, Doctor M. Landolina, Doctor K. Nakasuka...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources